CUV 1.42% $13.90 clinuvel pharmaceuticals limited

Wow, so they didn’t pause the buy back because they were being...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 16,680 Posts.
    lightbulb Created with Sketch. 4510
    Wow, so they didn’t pause the buy back because they were being diligent with respect to avoiding insider trading prior to the release of news, they simply forgot to press the buy button. It’s as if they want investors to vote NO at the AGM. Unless they have something incredibly impressive to announce between now and 16 October, a NO vote will almost certainly be the outcome.

    A phenomenally well run company with incredibly compelling fundamentals that will continue to perform well, but they need to show investors they care about them. It’s so easy for them to do, max out the buy back. It won’t take much cash, it won’t detract in any way shape or form from the core business. This is the reason it is so undervalued relative to its fundamentals and peer valuations though, they don’t even try to address the needs of shareholders.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$13.90
Change
-0.200(1.42%)
Mkt cap ! $695.8M
Open High Low Value Volume
$14.08 $14.12 $13.86 $1.006M 72.13K

Buyers (Bids)

No. Vol. Price($)
1 210 $13.90
 

Sellers (Offers)

Price($) Vol. No.
$13.94 576 1
View Market Depth
Last trade - 16.10pm 18/10/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.